Publication: Trastuzumab deruxtecan in her2-low breast cancer
| dc.contributor.coauthor | Özbalak, Murat | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.kuauthor | Birtaş Ateşoğlu, Elif | |
| dc.contributor.kuauthor | Ferhanoğlu, Ahmet Burhan | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.date.accessioned | 2024-11-09T23:26:44Z | |
| dc.date.issued | 2022 | |
| dc.description.indexedby | WOS | |
| dc.description.issue | 12 | |
| dc.description.openaccess | NO | |
| dc.description.publisherscope | International | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.volume | 387 | |
| dc.identifier.eissn | 1533-4406 | |
| dc.identifier.issn | 0028-4793 | |
| dc.identifier.quartile | Q1 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/11585 | |
| dc.identifier.wos | 865461700017 | |
| dc.language.iso | eng | |
| dc.publisher | Massachusetts Medical Soc | |
| dc.relation.ispartof | New England Journal of Medicine | |
| dc.subject | Medicine | |
| dc.subject | General | |
| dc.subject | Internal | |
| dc.title | Trastuzumab deruxtecan in her2-low breast cancer | |
| dc.type | Letter | |
| dspace.entity.type | Publication | |
| local.contributor.kuauthor | Ferhanoğlu, Ahmet Burhan | |
| local.contributor.kuauthor | Birtaş Ateşoğlu, Elif | |
| local.publication.orgunit1 | SCHOOL OF MEDICINE | |
| local.publication.orgunit2 | School of Medicine | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
